Try our Advanced Search for more refined results

Carl Washington et al v. CVS Pharmacy Inc.

  1. January 28, 2022

    CVS Drug Buyers Ask 9th Circ. For Redo Of $121M Trial

    Legal errors by a California federal court during a June trial prejudiced a jury, leading it to clear CVS Pharmacy Inc. of claims that it overcharged insured drug buyers by more than $121 million for generic drugs, multiple buyer classes told the Ninth Circuit in an opening brief.

  2. June 23, 2021

    Calif. Jury Clears CVS In $121M Drug Overcharge Trial

    A California federal jury on Wednesday cleared CVS Pharmacy Inc. of claims by multiple classes of insured drug buyers that the pharmacy chain overcharged them by more than $121 million for generic drugs, in violation of multiple state consumer protection statutes, according to CVS and attorneys for the classes.

  3. June 22, 2021

    CVS Drug Buyers Seek $121M As Overcharge Jury Trial Wraps

    Insured drug buyers' counsel urged a California federal jury to award 6.3 million CVS Pharmacy customers $121 million for overcharging them for generic drugs at the close of a weekslong trial Tuesday, while CVS' counsel argued it did nothing wrong and its pricing practices were in line with industry standards.

  4. June 21, 2021

    CVS Didn't Need To Report Drug Discounts To PBM, Jury Told

    A former OptumRx executive testified Monday during a California federal jury trial over class overcharge claims against CVS Pharmacy Inc. that the pharmacy benefit manager's contract with CVS didn't require CVS to report discounted drugs prices under its Health Savings Pass program, which customers allege led to higher insurance copays.

  5. June 16, 2021

    Express Scripts Was Unaware Of CVS Overcharges, Jury Told

    An Express Scripts executive told a California federal jury Wednesday that the pharmacy benefit manager was unaware CVS Pharmacy Inc. overcharged insured customers and didn't report its discounted drug prices, which the consumer classes claim led to higher copays.

  6. June 14, 2021

    CVS Overcharged Insured Drug Buyers $123.7M, Jury Told

    An expert hired by classes of insured drug buyers testified before a California federal jury Monday that CVS Pharmacy Inc. overcharged 6.6 million class members in six states a total of $123.7 million for generic drugs.

  7. June 11, 2021

    Ex-CVS Exec Probed On Drug Prices In Overcharge Trial

    A former CVS Pharmacy executive conceded to a California federal jury trial Friday that the chain didn't report its discounted drug prices to pharmacy benefit managers to avoid losing about $500 million annually.

  8. June 10, 2021

    CVS Pricing Practice 'Cheated' Insured Drug Buyers, Jury Told

    Drug buyers leading a class action alleging CVS Pharmacy Inc.'s now-defunct discount program overcharged insured customers for generic drugs took the stand in a California federal jury trial Thursday, testifying that they believe CVS "cheated" them out of lower copays and lied about their insurance coverage for years.

  9. June 08, 2021

    CVS Drug Buyers Demand $100M As Overcharge Trial Opens

    Counsel for classes of drug buyers told a California federal jury during trial openings Tuesday that CVS Pharmacy Inc. unfairly overcharged insured customers by nearly $100 million for generics under a now-defunct discount program, while the pharmacy chain's counsel said 95% of insured customers paid less than they would have otherwise.

  10. June 02, 2021

    CVS Judge Slams 'Totally Inappropriate' Trial Instructions

    A California federal judge refused Wednesday to decertify a class of drug buyers who allege CVS Pharmacy Inc. overcharged them for generic drugs, while criticizing counsel for both sides for proposing "totally inappropriate" jury instructions for the socially distanced trial that kicks off Monday.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!